Nutraceutical Ingredients Market by Ingredient Type (Functional Proteins, Amino Acids, Probiotics, Others), Application (Human Nutrition, Animal Nutrition), Source (Plant-Based, Animal-Based, Others), Function, and Region - Global Forecast to 2031

icon1
USD 161.53 BN
MARKET SIZE, 2031
icon2
CAGR 7.3%
(2026-2031)
icon3
625
REPORT PAGES
icon4
705
MARKET TABLES

OVERVIEW

nutraceutical-ingredient-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The nutraceutical ingredients market size is projected to reach USD 161.53 billion by 2031 from USD 108.33 billion in 2026, growing at a CAGR of 7.3%. The market is driven by increasing demand for health and wellness products, growing consumer interest in preventive nutrition, and the adoption of functional ingredients across dietary supplements, functional foods and beverages, medical and specialized nutrition, and infant and early-life nutrition, alongside increasing use of specialized nutritional solutions to support animal health, performance, and well-being. Nutraceutical ingredients are incorporated into a wide range of products to provide nutritional and functional benefits, while growing demand for digestive health, immunity, healthy aging, sports and performance, and overall nutritional support is creating opportunities across human and animal nutrition. Additionally, manufacturers are developing ingredients with improved stability, bioavailability, functionality, and formulation compatibility to meet evolving product requirements. Product innovation and advances in ingredient processing and formulation are expected to support continued market development across diverse nutrition applications.

KEY TAKEAWAYS

  • By Region
    Asia Pacific is expected to be the largest and fastest-growing region in the nutraceutical ingredients market, registering a CAGR of 11.3% during the forecast period.
  • By Application
    By application, human nutrition held the largest share of the nutraceutical ingredients market in 2025 and is projected to be the fastest-growing segment during the forecast period, registering a CAGR of 8.49%.
  • By Ingredient Type
    By ingredient type, functional proteins held the largest share of the nutraceutical ingredients market in 2025, accounting for 44.34% of the total market.
  • By Source
    By source, microbial-based ingredients are projected to be the fastest-growing segment of the nutraceutical ingredients market during the forecast period, registering a CAGR of 10.21%.
  • Competitive Landscape (Key Players)
    Cargill, ADM, BASF, Glanbia, Ingredion, Tate & Lyle, and Roquette are key players due to their broad nutraceutical ingredient portfolios, manufacturing capabilities, and presence across multiple nutrition applications.
  • Competitive Landscape (Startups/SMEs)
    Sarsika Pharmachem, Canura Naturals, and EVANIUM have established a presence among startups and SMEs due to their focus on specialized nutraceutical ingredients and targeted ingredient solutions.

The nutraceutical ingredients market is driven by increasing demand for nutritional and functional benefits across dietary supplements, functional foods and beverages, medical and specialized nutrition, and infant and early-life nutrition. Growing focus on preventive healthcare, healthy aging, sports nutrition, and personalized nutrition is supporting demand for targeted nutritional solutions, while increasing focus on animal health, digestive function, immunity, and performance is supporting demand for nutraceutical ingredients in animal nutrition. Advances in ingredient processing and formulation are further improving stability, bioavailability, and application flexibility.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The impact on stakeholders across the nutraceutical ingredients market is driven by growing demand for targeted health and wellness formulations, improved ingredient efficacy and bioavailability, convenient delivery formats, and clean-label and sustainably sourced ingredients. Ingredient manufacturers primarily serve dietary supplement manufacturers, functional food and beverage manufacturers, medical and specialized nutrition manufacturers, infant and early-life nutrition manufacturers, and personalized nutrition providers. As manufacturers increasingly seek ingredients that address specific health needs while meeting formulation and quality requirements, demand is shifting toward clinically supported ingredients, personalized nutrition solutions, and ingredients with improved functionality and bioavailability. The evolution of the market reflects changing requirements across the nutraceutical ingredients value chain. Traditional ingredient solutions focused mainly on standard vitamins and minerals, conventional botanical and herbal ingredients, basic protein and amino acid ingredients, and standard probiotic and prebiotic products. Manufacturers are increasingly developing value-added solutions such as targeted health ingredients, ingredients supporting healthy aging and longevity, gut health and immune support, personalized and clean-label nutrition, convenient functional foods and beverages, and ingredients that support animal health, nutrition, and performance. These priorities ultimately support greater availability of targeted nutrition products, broader product choice, increased adoption of convenient functional foods and beverages, greater interest in personalized and clean-label nutrition, and improved solutions for animal health and nutrition.

nutraceutical-ingredient-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Increasing Adoption of Dietary Supplements and Targeted Health Products
  • Growing Demand for Fortified and Functionally Enhanced Foods and Beverages
RESTRAINTS
Impact
Level
  • Higher Costs Associated with Fortification and Functional Formulation
  • Stringent Regulatory Requirements and Health-Claim Restrictions
OPPORTUNITIES
Impact
Level
  • Widespread Micronutrient Deficiencies and Continued Use of Fortification and Supplementation
  • Growing Demand for Preventive and Healthy Aging Nutrition
CHALLENGES
Impact
Level
  • Advancements in Delivery Technologies Enhancing Bioavailability and Stability of Nutraceutical Ingredients
  • Variability and Quality-Control Challenges for Botanical and Natural Ingredients

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Increasing Adoption of Dietary Supplements and Targeted Health Products

Increasing consumer focus on health, wellness, and preventive nutrition is driving demand for dietary supplements and targeted health products. Manufacturers are responding by developing supplements formulated to address specific nutritional needs and health objectives, using ingredients such as vitamins, minerals, amino acids, probiotics, botanicals, and other specialty ingredients. The growing emphasis on targeted nutrition is encouraging the use of specialized formulations for areas such as immune, digestive, cardiovascular, and healthy aging support. As consumers increasingly seek products tailored to specific health and nutritional requirements, demand for nutraceutical ingredients is expected to increase across dietary supplements and targeted health products.

Restraint: Higher Costs Associated with Fortification and Functional Formulation

Higher costs associated with fortification and functional formulation can limit the adoption of nutraceutical ingredients, particularly when manufacturers incorporate multiple ingredients or develop products with specific nutritional and functional requirements. Additional costs can arise from ingredient sourcing, formulation, processing, quality control, and testing to ensure ingredient stability, compatibility, and consistency. These factors can increase the overall production cost of fortified and functionally enhanced products and may limit adoption among manufacturers operating in price-sensitive markets.

Opportunity: Widespread Micronutrient Deficiencies and Continued Use of Fortification and Supplementation

Persistent micronutrient deficiencies are supporting the continued use of food fortification and dietary supplementation to improve the intake of essential nutrients. Governments and food manufacturers use fortification to add vitamins and minerals to commonly consumed foods, while dietary supplements provide concentrated sources of nutrients for individuals and population groups with specific nutritional requirements. This continued reliance on fortification and supplementation is supporting demand for nutraceutical ingredients such as vitamins and minerals, particularly in applications where conventional diets may not provide adequate nutrient intake.

Challenge: Advancements in Delivery Technologies Enhancing Bioavailability and Stability of Nutraceutical Ingredients

Advancements in delivery technologies are enabling manufacturers to overcome limitations associated with the poor solubility, stability, and bioavailability of certain nutraceutical ingredients. Technologies such as microencapsulation, nanoencapsulation, emulsification, liposomes, and lipid-based delivery systems can protect sensitive ingredients from degradation caused by heat, light, oxygen, and gastrointestinal conditions while improving their dispersion and absorption. These technologies are particularly relevant for ingredients such as fat-soluble vitamins, carotenoids, polyphenols, omega-3 fatty acids, and other bioactive compounds, supporting their incorporation into a broader range of dietary supplements, functional foods, and beverages.

NUTRACEUTICAL INGREDIENTS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
company logo
 Uses Cargill’s EpiCor postbiotic in BloomDays, a plant-based, sugar-free postbiotic gummy providing 500 mg of EpiCor per two-gummy serving Enables incorporation of a stable postbiotic ingredient into a convenient gummy format for immune- and gut-health positioning
company logo
 Uses Kerry’s Wellmune beta-glucan in its Mushroom Immune with Beta Glucans dietary supplement; the product contains 250 mg of Wellmune, a highly purified beta-1,3/1,6-glucan derived from baker’s yeast, alongside shiitake, maitake, and chaga mushroom powders Supports a balanced and healthy immune response; life Extension selected Wellmune based on its clinical support for immune-health applications and uses it to provide a clinically studied dose of yeast-derived beta-glucan in a once-daily capsule
company logo
 Uses PeptoPro, a peptide-based protein ingredient developed by dsm-firmenich, in its BORN RECOVERY+ recovery drink; the product contains 10 g of PeptoPro per serving and is formulated for consumption within 30 minutes after exercise Provides a rapidly absorbed protein source to support muscle recovery and muscle building after endurance exercise, while enabling a convenient recovery-drink format

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The nutraceutical ingredients market ecosystem comprises manufacturers of nutraceutical ingredients (Cargill, dsm-firmenich, ADM, Ingredion, Arla Foods Ingredients, Roquette, and Kerry), technology providers (GEA, Bühler, Glatt, SPX FLOW, and Syntegon), associations and regulatory bodies (GOED, FSSAI, FDA, CRN, and EFSA), and end users (Abbott, Kellanova, Nestlé Health Science, Haleon, Yakult, Danone, and Herbalife). Manufacturers supply ingredients such as vitamins, minerals, specialty lipids, probiotics, botanical extracts, proteins, and amino acids for use in dietary supplements, functional foods and beverages, sports nutrition, and specialized nutrition products. Technology providers support processing, formulation, drying, granulation, encapsulation, and packaging, while associations and regulatory bodies support safety, standards, scientific guidance, and regulatory compliance. End users incorporate these ingredients into finished nutrition, health, wellness, and functional products targeting applications such as immune health, digestive health, cardiovascular health, sports nutrition, and nutritional supplementation.

nutraceutical-ingredient-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

nutraceutical-ingredient-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Nutraceutical Ingredients Market, by Ingredient Type

Functional proteins are expected to account for the largest share of the nutraceutical ingredients market, supported by increasing demand for protein-enriched products across dietary supplements, functional foods, functional beverages, and specialized nutrition. Functional proteins are increasingly incorporated into protein powders, bars, ready-to-drink beverages, fortified foods, and other nutrition products to support protein intake, muscle maintenance, recovery, and overall nutritional enrichment. Demand is further supported by growing participation in fitness and active lifestyles and increasing consumer interest in convenient protein formats. Manufacturers are also expanding functional protein portfolios across dairy-based and plant-based sources, enabling their use across a broader range of formulations and consumer preferences. The continued expansion of protein-enriched products and convenient delivery formats is expected to support the leading position of functional proteins in the nutraceutical ingredients market.

Nutraceutical Ingredients Market, by Source

Plant-based ingredients are expected to account for the largest share of the nutraceutical ingredients market, supported by increasing demand for plant-derived proteins, fibers, and other functional ingredients across dietary supplements, functional foods, and beverages. Growing adoption of vegetarian, vegan, and flexitarian diets, together with consumer interest in health, sustainability, and alternative sources of nutrition, is encouraging manufacturers to expand the use of plant-based ingredients. Plant-based protein ingredients from sources such as soy, pea, rice, and other crops are increasingly incorporated into powders, bars, beverages, and fortified food products, while plant-derived ingredients are also used to support nutritional and functional positioning across a wider range of formulations. The expanding use of plant-based ingredients across multiple nutraceutical applications is expected to support their leading position in the market.

Nutraceutical Ingredients Market, by Application

Human nutrition is expected to account for the largest share of the nutraceutical ingredients market, supported by the broad use of nutraceutical ingredients in dietary supplements, functional foods, functional beverages, medical and specialized nutrition, and infant and early-life nutrition. Ingredient manufacturers supply proteins, amino acids, vitamins, minerals, probiotics, prebiotics, fibers, omega-3 fatty acids, carotenoids, and other ingredients for incorporation into products addressing nutritional supplementation, functional health, and specialized dietary requirements. Within human nutrition, ingredients are increasingly incorporated into convenient formats such as fortified foods, protein products, functional beverages, and dietary supplements as consumers seek accessible products that support health and nutrition. The broad application base and continued development of fortified and functional nutrition products are expected to support the leading position of Human Nutrition in the nutraceutical ingredients market.

REGION

Asia Pacific is expected to exhibit highest CAGR in nutraceutical ingredients market during forecast period

Asia Pacific is expected to be the fastest-growing region in the nutraceutical ingredients market, driven by increasing focus on preventive health, rising health awareness, and growing demand for dietary supplements and functional foods and beverages. Consumers across countries such as China, India, Japan, South Korea, and Australia are increasingly seeking products that support immunity, digestive health, healthy aging, and overall well-being. This is supporting demand for nutraceutical ingredients such as vitamins, minerals, probiotics, specialty lipids, botanical extracts, proteins, and amino acids. In addition, the expansion of sports nutrition, functional beverages, and targeted nutrition products is encouraging manufacturers to broaden their ingredient portfolios and develop products addressing specific health needs. Growing urbanization, changing lifestyles, and increasing interest in convenient and health-oriented nutrition are further supporting the adoption of nutraceutical ingredients across diverse applications. As demand for preventive health and functional nutrition continues to increase, Asia Pacific is expected to record the highest growth rate in the nutraceutical ingredients market.

nutraceutical-ingredient-market Region

NUTRACEUTICAL INGREDIENTS MARKET: COMPANY EVALUATION MATRIX

In the nutraceutical ingredients market matrix, ADM (Star) holds a strong position supported by its broad portfolio of specialty health ingredients, including prebiotic dietary fibers, nutritional oils, vitamin E, sterols, and soy isoflavones, serving multiple health and wellness applications. Kerry (Emerging Leader) has established a strong position through its portfolio of nutrition and health ingredients spanning enzymes, nutritional lipids, proteins, soluble dietary fiber, and wellness and health solutions, supporting applications related to digestion, immunity, cognition, and overall nutrition. While ADM benefits from a broader specialty health ingredient portfolio and product footprint, Kerry is strengthening its position through a diversified range of nutrition and wellness ingredients and application capabilities.

nutraceutical-ingredient-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2025 (Value) USD 101.04 billion
Market Forecast in 2026 (Value) USD 108.33 billion
Market Forecast in 2031 (Value) USD 161.53 billion
Growth Rate CAGR of 7.3% from 2026–2031
Years Considered 2022–2031
Base Year 2025
Forecast Period 2026–2031
Units Considered Value (USD Million/Billion), Volume (Tons)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Ingredient Type:
    • Functional Proteins
    • Omega-3 Fatty Acids
    • Probiotics
    • Prebiotics
    • Fibers & Specialty Carbohydrates
    • Vitamins (Vitamin A
    • Vitamin B
    • Vitamin C
    • Vitamin D
    • Vitamin E
    • Other Vitamins)
    • Minerals (Calcium
    • Magnesium
    • Iron
    • Zinc
    • Other Minerals)
    • Amino Acids (Branched-Chain Amino Acids
    • Essential Amino Acids
    • Non-Essential Amino Acids
    • Specialty Amino Acids)
    • Carotenoids
    • Other Types
  • By Source:
    • Plant-based
    • Animal-based
    • Microbial-based
    • Synthetics
  • By Application:
    • Human Nutrition (Dietary Supplements
    • Functional Foods
    • Functional Beverages
    • Medical & Specialized Nutrition
    • Infant & Early-Life Nutrition)
    • Animal Nutrition (Companion Animal Nutrition
    • Livestock Nutrition
    • Aquaculture Nutrition
    • Other Animal Nutrition)
Regions Covered North America, Asia Pacific, Europe, South America, RoW

WHAT IS IN IT FOR YOU: NUTRACEUTICAL INGREDIENTS MARKET REPORT CONTENT GUIDE

nutraceutical-ingredient-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Dietary Supplements Market
  • Analyzed demand across vitamins, minerals, botanicals, probiotics, amino acids, and specialty supplements
  • Evaluated adoption across tablets, capsules, powders, gummies, and liquid formats
  • Assessed consumer health priorities, formulation trends, distribution channels, and competitive positioning
  • Identified high-potential supplement categories and delivery formats
  • Provided insights on ingredient integration, product development, and portfolio expansion opportunities
Functional Food & Beverage Market
  • Assessed demand for functional foods and beverages incorporating vitamins, minerals, probiotics, prebiotics, botanical extracts, proteins, and specialty ingredients
  • Evaluated applications across dairy and dairy alternatives, beverages, bakery, snacks, and other functional food products
  • Analyzed formulation trends, health-positioning strategies, and competitive landscape
  • Identified opportunities for nutraceutical ingredient integration across food and beverage applications
  • Provided insights on product innovation, health-focused formulations, and application expansion
Sports Nutrition Market
  • Analyzed demand across protein, amino acids, vitamins, minerals, electrolytes, probiotics, and other performance-oriented ingredients
  • Evaluated applications across sports drinks, protein powders, bars, gels, and dietary supplements
  • Assessed consumer preferences, formulation trends, product positioning, and competitive strategies
  • Identified opportunities in performance, recovery, hydration, and active-aging applications
  • Provided insights on ingredient portfolio expansion and development of targeted sports nutrition formulations

RECENT DEVELOPMENTS

  • July 2026 : dsm-firmenich was awarded five 2026 Nutrition Research Grants, each worth EUR 50,000 (~USD 54,000), to support research on nutrition and bioactives for healthy longevity in Asia Pacific. The grants covered research on postbiotics, polyphenols, omega-3, vitamin D, trigonelline, and CoQ10.
  • February 2026 : Roquette launched NUTRALYS Pea 850F, a pea protein isolate with a clean, neutral taste profile designed for ready-to-mix and ready-to-drink products, dairy alternatives, beverages, and specialized nutrition applications.
  • January 2026 : Glanbia acquired 100% of Scicore Nutra Private Limited for an initial consideration of USD 15.1 million, plus deferred consideration of up to USD 1.3 million. Scicore was an India-based nutritional products manufacturer, strengthening Glanbia’s Health & Nutrition manufacturing capabilities.
  • September 2025 : Arla Foods Ingredients partnered with Aarhus University and Steno Diabetes Center Aarhus to conduct a randomized clinical study on Lacprodan® ISO.WaterShake whey protein isolate in women with gestational diabetes. The study found that pre-meal consumption of whey protein reduced post-meal blood glucose peaks.

 

Table of Contents

checkmarkExclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
 
47
2
EXECUTIVE SUMMARY
 
 
 
 
 
54
3
PREMIUM INSIGHTS
 
 
 
 
 
59
4
MARKET OVERVIEW
Seize growth by leveraging fortified foods, addressing micronutrient deficiencies, and enhancing ingredient bioavailability.
 
 
 
 
 
64
 
4.1
INTRODUCTION
 
 
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
 
 
 
4.2.1.1
INCREASING ADOPTION OF DIETARY SUPPLEMENTS AND TARGETED HEALTH PRODUCTS
 
 
 
 
 
 
4.2.1.2
GROWING DEMAND FOR FORTIFIED AND FUNCTIONALLY ENHANCED FOODS AND BEVERAGES
 
 
 
 
 
 
4.2.1.3
RISING INCIDENCE OF CHRONIC DISEASES
 
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
 
 
 
4.2.2.1
HIGH COST AND PRICE VOLATILITY OF NUTRACEUTICAL INGREDIENTS
 
 
 
 
 
 
4.2.2.2
STRINGENT REGULATORY REQUIREMENTS AND HEALTH-CLAIM RESTRICTIONS
 
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
 
 
 
4.2.3.1
WIDESPREAD MICRONUTRIENT DEFICIENCIES AND CONTINUED USE OF FORTIFICATION AND SUPPLEMENTATION
 
 
 
 
 
 
4.2.3.2
GROWING DEMAND FOR PREVENTIVE AND HEALTHY AGING NUTRITION
 
 
 
 
 
 
4.2.3.3
ADVANCEMENTS IN DELIVERY TECHNOLOGIES ENHANCING BIOAVAILABILITY AND STABILITY OF NUTRACEUTICAL INGREDIENTS
 
 
 
 
 
4.2.4
CHALLENGES
 
 
 
 
 
 
 
4.2.4.1
VARIABILITY AND QUALITY-CONTROL CHALLENGES FOR BOTANICAL AND NATURAL INGREDIENTS
 
 
 
 
 
 
4.2.4.2
SUPPLY CHAIN DISRUPTIONS AND AVAILABILITY OF NUTRACEUTICAL RAW MATERIALS
 
 
 
 
4.3
UNMET NEEDS AND WHITE SPACES
 
 
 
 
 
 
 
4.3.1
UNMET NEEDS IN NUTRACEUTICAL INGREDIENTS MARKET
 
 
 
 
 
 
4.3.2
WHITE SPACE OPPORTUNITIES
 
 
 
 
 
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
 
 
4.4.1
INTERCONNECTED MARKETS
 
 
 
 
 
 
4.4.2
CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
 
 
 
 
4.5.1
KEY MOVES AND STRATEGIC FOCUS
 
 
 
 
5
INDUSTRY TRENDS
Navigate evolving market dynamics with strategic insights into competitive forces and pricing trends.
 
 
 
 
 
84
 
5.1
INTRODUCTION
 
 
 
 
 
 
5.2
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
 
5.2.1
THREAT OF NEW ENTRANTS
 
 
 
 
 
 
5.2.2
THREAT OF SUBSTITUTES
 
 
 
 
 
 
5.2.3
BARGAINING POWER OF SUPPLIERS
 
 
 
 
 
 
5.2.4
BARGAINING POWER OF BUYERS
 
 
 
 
 
 
5.2.5
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
 
 
5.3
MACROECONOMIC INDICATORS
 
 
 
 
 
 
 
5.3.1
GLOBAL HEALTHCARE EXPENDITURE
 
 
 
 
 
 
5.3.2
REAL HOUSEHOLD INCOME
 
 
 
 
 
5.4
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
 
 
5.4.1
RAW MATERIAL SOURCING
 
 
 
 
 
 
5.4.2
EXTRACTION & PROCESSING
 
 
 
 
 
 
5.4.3
INGREDIENT MANUFACTURING & STANDARDIZATION
 
 
 
 
 
 
5.4.4
QUALITY ASSURANCE, R&D & REGULATORY
 
 
 
 
 
 
5.4.5
COMMERCIALIZATION & DISTRIBUTION
 
 
 
 
 
 
5.4.6
INGREDIENT APPLICATION
 
 
 
 
 
5.5
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
 
 
5.5.1
DEMAND SIDE
 
 
 
 
 
 
5.5.2
SUPPLY SIDE
 
 
 
 
 
5.6
PRICING ANALYSIS
 
 
 
 
 
 
 
 
5.6.1
INDICATIVE PRICE TREND AMONG MARKET PLAYERS
 
 
 
 
 
 
5.6.2
AVERAGE SELLING PRICE TREND, BY INGREDIENT TYPE
 
 
 
 
 
 
5.6.3
AVERAGE SELLING PRICE TREND, BY REGION
 
 
 
 
 
5.7
TRADE ANALYSIS
 
 
 
 
 
 
 
 
5.7.1
TRADE ANALYSIS OF HS CODE 2936: PROVITAMINS AND VITAMINS
 
 
 
 
 
 
 
5.7.1.1
EXPORT TRENDS OF HS CODE 2936 (2021–2025)
 
 
 
 
 
 
5.7.1.2
IMPORT TRENDS UNDER HS CODE 2936 (2021–2025)
 
 
 
 
5.8
KEY CONFERENCES & EVENTS
 
 
 
 
 
 
5.9
TRENDS IMPACTING CUSTOMERS’ BUSINESSES
 
 
 
 
 
 
5.10
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
 
 
5.11
CASE STUDY ANALYSIS
 
 
 
 
 
 
 
5.11.1
DSM-FIRMENICH SUPPORTED KOREA EUNDAN’S TRANSITION TO ALGAL OMEGA-3
 
 
 
 
 
 
5.11.2
KERRY – BC30 PROBIOTIC IN FUNCTIONAL HOT BEVERAGE
 
 
 
 
 
 
5.11.3
INGREDION – VITESSENCE PULSE 1853 PEA PROTEIN IN VEGAN BEVERAGE
 
 
 
 
 
5.12
IMPACT OF US TARIFF – NUTRACEUTICAL INGREDIENTS MARKET
 
 
 
 
 
 
 
 
5.12.1
INTRODUCTION
 
 
 
 
 
 
5.12.2
PRICE IMPACT ANALYSIS
 
 
 
 
 
 
5.12.3
IMPACT ON COUNTRY/REGION
 
 
 
 
 
 
 
5.12.3.1
US
 
 
 
 
 
 
5.12.3.2
EUROPE
 
 
 
 
 
 
5.12.3.3
ASIA PACIFIC
 
 
 
 
 
5.12.4
IMPACT ON END-USE INDUSTRIES
 
 
 
 
6
REGULATORY AND SUSTAINABILITY LANDSCAPE
Navigate complex regulations to enhance sustainability and efficiency in the nutraceutical ingredients sector.
 
 
 
 
 
112
 
6.1
INTRODUCTION
 
 
 
 
 
 
6.2
REGIONAL REGULATIONS AND COMPLIANCE
 
 
 
 
 
 
 
6.2.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
6.2.2
INDUSTRY STANDARDS
 
 
 
 
 
6.3
SUSTAINABILITY INITIATIVES
 
 
 
 
 
 
 
6.3.1
SUSTAINABLE AND RESPONSIBLE SOURCING
 
 
 
 
 
 
6.3.2
RESOURCE EFFICIENCY AND LOW-CARBON MANUFACTURING
 
 
 
 
 
 
6.3.3
CIRCULAR ECONOMY AND SUSTAINABLE PRODUCTION
 
 
 
 
 
 
6.3.4
CIRCULAR ECONOMY AND FOOD WASTE REDUCTION
 
 
 
 
 
6.4
IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
 
 
 
 
 
 
6.5
CERTIFICATIONS, LABELING, ECO-STANDARDS
 
 
 
 
 
7
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
AI-driven innovations revolutionize sustainable protein production and personalized nutrition through advanced technologies.
 
 
 
 
 
129
 
7.1
INTRODUCTION
 
 
 
 
 
 
7.2
KEY TECHNOLOGIES
 
 
 
 
 
 
 
7.2.1
ADVANCED EXTRACTION & PURIFICATION TECHNOLOGIES
 
 
 
 
 
 
7.2.2
PRECISION FERMENTATION & ADVANCED BIOPROCESSING
 
 
 
 
 
 
7.2.3
ENCAPSULATION & ADVANCED DELIVERY SYSTEMS
 
 
 
 
 
7.3
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
 
 
7.3.1
ADVANCED ANALYTICAL & CHARACTERIZATION TECHNOLOGIES
 
 
 
 
 
 
7.3.2
NANOTECHNOLOGY & ADVANCED FORMULATION TECHNOLOGIES
 
 
 
 
 
 
7.3.3
AUTOMATION, PROCESS MONITORING & DIGITAL MANUFACTURING TECHNOLOGIES
 
 
 
 
 
7.4
ADJACENT TECHNOLOGIES
 
 
 
 
 
 
 
7.4.1
SYNTHETIC BIOLOGY & BIOINFORMATICS
 
 
 
 
 
 
7.4.2
PERSONALIZED NUTRITION & DIGITAL HEALTH TECHNOLOGIES
 
 
 
 
 
 
7.4.3
ADVANCED FOOD PROCESSING & 3D FOOD-PRINTING TECHNOLOGIES
 
 
 
 
 
7.5
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
 
 
 
7.5.1
SHORT-TERM | OPTIMIZATION OF EXTRUSION PROCESSES AND CLEAN-LABEL PRODUCT DEVELOPMENT
 
 
 
 
 
 
7.5.2
MID-TERM | INTELLIGENT MANUFACTURING AND COMMERCIALIZATION OF NEXT-GENERATION PROTEIN INGREDIENTS
 
 
 
 
 
 
7.5.3
LONG-TERM | AUTONOMOUS AI-DRIVEN MANUFACTURING AND SUSTAINABLE PROTEIN INNOVATION
 
 
 
 
 
7.6
PATENT ANALYSIS
 
 
 
 
 
 
 
 
7.6.1
LIST OF MAJOR PATENTS
 
 
 
 
 
7.7
FUTURE APPLICATIONS
 
 
 
 
 
 
 
7.7.1
PERSONALIZED & PRECISION NUTRITION
 
 
 
 
 
 
7.7.2
FUNCTIONAL & SPECIALIZED NUTRITION PRODUCTS
 
 
 
 
 
7.8
IMPACT OF GENERATIVE AI ON NUTRACEUTICAL INGREDIENTS MARKET
 
 
 
 
 
 
 
7.8.1
INTRODUCTION
 
 
 
 
 
 
7.8.2
TOP USE CASES AND MARKET POTENTIAL
 
 
 
 
 
 
7.8.3
BEST PRACTICES IN NUTRACEUTICAL INGREDIENTS INDUSTRY
 
 
 
 
 
 
7.8.4
CASE STUDIES OF AI IMPLEMENTATION IN NUTRACEUTICAL INGREDIENTS MARKET
 
 
 
 
 
 
7.8.5
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
 
 
 
 
 
 
7.8.6
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN NUTRACEUTICAL INGREDIENTS MARKET
 
 
 
 
 
7.9
SUCCESS STORIES AND REAL-WORLD APPLICATIONS
 
 
 
 
 
8
CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
Uncover decision influencers and unmet needs shaping buyer behavior in diverse industries.
 
 
 
 
 
142
 
8.1
INTRODUCTION
 
 
 
 
 
 
8.2
DECISION-MAKING PROCESS
 
 
 
 
 
 
8.3
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
 
 
 
 
 
 
 
8.3.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
 
 
8.3.2
BUYING CRITERIA
 
 
 
 
 
8.4
ADOPTION BARRIERS AND INTERNAL CHALLENGES
 
 
 
 
 
 
8.5
UNMET NEEDS OF VARIOUS END-USE INDUSTRIES
 
 
 
 
 
 
8.6
MARKET PROFITABILITY
 
 
 
 
 
9
NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTION
Market Size & Growth Rate Forecast Analysis
 
 
 
 
 
152
 
9.1
INTRODUCTION
 
 
 
 
 
 
9.2
NUTRITIONAL SUPPORT
 
 
 
 
 
 
9.3
DIGESTIVE HEALTH
 
 
 
 
 
 
9.4
IMMUNE HEALTH
 
 
 
 
 
 
9.5
CARDIOVASCULAR HEALTH
 
 
 
 
 
 
9.6
BONE & JOINT HEALTH
 
 
 
 
 
 
9.7
COGNITIVE & MENTAL HEALTH
 
 
 
 
 
 
9.8
SPORTS & PERFORMANCE
 
 
 
 
 
 
9.9
WEIGHT MANAGEMENT
 
 
 
 
 
 
9.10
OTHERS (BEAUTY & HEALTHY AGING, ETC.)
 
 
 
 
 
10
NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million and Tons | 80 Data Tables
 
 
 
 
 
158
 
10.1
INTRODUCTION
 
 
 
 
 
 
10.2
FUNCTIONAL PROTEINS
 
 
 
 
 
 
 
10.2.1
NUTRITIONAL FUNCTIONALITY AND EXPANDING APPLICATIONS
 
 
 
 
 
10.3
OMEGA-3 FATTY ACIDS
 
 
 
 
 
 
 
10.3.1
GROWING DEMAND FOR CARDIOVASCULAR, COGNITIVE, AND PREVENTIVE NUTRITION
 
 
 
 
 
10.4
PROBIOTICS
 
 
 
 
 
 
 
10.4.1
EXPANDING APPLICATIONS IN GUT HEALTH AND FUNCTIONAL NUTRITION
 
 
 
 
 
10.5
PREBIOTICS
 
 
 
 
 
 
 
10.5.1
SUPPORTING GUT MICROBIOME HEALTH AND FUNCTIONAL NUTRITION
 
 
 
 
 
10.6
FIBERS & SPECIALTY CARBOHYDRATES
 
 
 
 
 
 
 
10.6.1
EXPANDING ROLE IN DIGESTIVE HEALTH AND PRODUCT FORMULATION
 
 
 
 
 
10.7
VITAMINS
 
 
 
 
 
 
 
10.7.1
ESSENTIAL MICRONUTRIENTS SUPPORTING PREVENTIVE AND SPECIALIZED NUTRITION
 
 
 
 
 
 
10.7.2
VITAMIN A
 
 
 
 
 
 
10.7.3
VITAMIN B
 
 
 
 
 
 
10.7.4
VITAMIN C
 
 
 
 
 
 
10.7.5
VITAMIN D
 
 
 
 
 
 
10.7.6
VITAMIN E
 
 
 
 
 
 
10.7.7
OTHER VITAMINS (MULTIVITAMIN, ETC.)
 
 
 
 
 
10.8
MINERALS
 
 
 
 
 
 
 
10.8.1
ESSENTIAL MICRONUTRIENTS ACROSS SUPPLEMENTATION, FORTIFICATION, AND SPECIALIZED NUTRITION
 
 
 
 
 
 
10.8.2
CALCIUM
 
 
 
 
 
 
10.8.3
MAGNESIUM
 
 
 
 
 
 
10.8.4
IRON
 
 
 
 
 
 
10.8.5
ZINC
 
 
 
 
 
 
10.8.6
OTHER MINERALS
 
 
 
 
 
10.9
AMINO ACIDS
 
 
 
 
 
 
 
10.9.1
EXPANDING ROLE IN TARGETED NUTRITION, SPORTS PERFORMANCE, AND METABOLIC SUPPORT
 
 
 
 
 
 
10.9.2
BRANCHED-CHAIN AMINO ACIDS
 
 
 
 
 
 
10.9.3
ESSENTIAL AMINO ACIDS
 
 
 
 
 
 
10.9.4
NON-ESSENTIAL AMINO ACIDS
 
 
 
 
 
 
10.9.5
SPECIALTY AMINO ACIDS
 
 
 
 
 
10.10
CAROTENOIDS
 
 
 
 
 
 
 
10.10.1
NATURAL PIGMENTS WITH EXPANDING NUTRITIONAL AND FUNCTIONAL APPLICATIONS
 
 
 
 
 
10.11
OTHER INGREDIENT TYPES
 
 
 
 
 
11
NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 10 Data Tables
 
 
 
 
 
200
 
11.1
INTRODUCTION
 
 
 
 
 
 
11.2
PLANT-BASED
 
 
 
 
 
 
 
11.2.1
EXPANSION OF PLANT-BASED SUPPLY AND PROCESSING CAPACITY TO DRIVE NUTRACEUTICAL INGREDIENT MARKET GROWTH
 
 
 
 
 
11.3
ANIMAL-BASED
 
 
 
 
 
 
 
11.3.1
GROWING DEMAND FOR HIGH-PROTEIN AND BIOACTIVE INGREDIENTS TO DRIVE ANIMAL-BASED INGREDIENT GROWTH
 
 
 
 
 
11.4
MICROBIAL-BASED
 
 
 
 
 
 
 
11.4.1
EXPANSION OF MICROBIAL-DERIVED INGREDIENTS AND FERMENTATION-BASED PRODUCTION TO DRIVE MARKET GROWTH
 
 
 
 
 
11.5
SYNTHETICS
 
 
 
 
 
 
 
11.5.1
CONSISTENT QUALITY AND SCALABLE PRODUCTION OF SYNTHETIC INGREDIENTS TO SUPPORT MARKET GROWTH
 
 
 
 
12
NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 28 Data Tables
 
 
 
 
 
209
 
12.1
INTRODUCTION
 
 
 
 
 
 
12.2
HUMAN NUTRITION
 
 
 
 
 
 
 
12.2.1
DIETARY SUPPLEMENTS
 
 
 
 
 
 
 
12.2.1.1
DIETARY SUPPLEMENTS REMAIN LARGEST APPLICATION FOR NUTRACEUTICAL INGREDIENTS DUE TO THEIR ESTABLISHED CONSUMER ACCEPTANCE
 
 
 
 
 
12.2.2
FUNCTIONAL FOODS
 
 
 
 
 
 
 
12.2.2.1
GROWING HEALTH-CONSCIOUS CONSUMPTION IS DRIVING NUTRACEUTICAL INGREDIENT ADOPTION IN FUNCTIONAL FOODS
 
 
 
 
 
12.2.3
FUNCTIONAL BEVERAGES
 
 
 
 
 
 
 
12.2.3.1
DEMAND FOR CONVENIENT WELLNESS PRODUCTS IS ACCELERATING NUTRACEUTICAL INGREDIENT USE IN BEVERAGES
 
 
 
 
 
12.2.4
MEDICAL & SPECIALIZED NUTRITION
 
 
 
 
 
 
 
12.2.4.1
RISING DEMAND FOR TARGETED NUTRITION IS SUPPORTING USE OF SPECIALTY NUTRACEUTICAL INGREDIENTS
 
 
 
 
 
12.2.5
INFANT & EARLY-LIFE NUTRITION
 
 
 
 
 
 
 
12.2.5.1
GREATER FOCUS ON EARLY-LIFE HEALTH IS DRIVING DEMAND FOR HIGH-QUALITY NUTRACEUTICAL INGREDIENTS
 
 
 
 
12.3
ANIMAL NUTRITION
 
 
 
 
 
 
 
12.3.1
COMPANION ANIMAL NUTRITION
 
 
 
 
 
 
 
12.3.1.1
PET HUMANIZATION IS ACCELERATING DEMAND FOR NUTRACEUTICAL INGREDIENTS IN COMPANION ANIMAL NUTRITION
 
 
 
 
 
12.3.2
LIVESTOCK NUTRITION
 
 
 
 
 
 
 
12.3.2.1
REDUCED RELIANCE ON ANTIBIOTICS IS DRIVING NUTRACEUTICAL ADOPTION IN LIVESTOCK NUTRITION
 
 
 
 
 
12.3.3
AQUACULTURE NUTRITION
 
 
 
 
 
 
 
12.3.3.1
GROWING AQUACULTURE PRODUCTION IS INCREASING DEMAND FOR FUNCTIONAL NUTRITION INGREDIENTS
 
 
 
 
 
12.3.4
OTHER ANIMAL NUTRITION
 
 
 
 
 
 
 
12.3.4.1
SPECIALIZED ANIMAL HEALTH NEEDS ARE CREATING DEMAND FOR TARGETED NUTRACEUTICAL INGREDIENTS
 
 
 
13
NUTRACEUTICAL INGREDIENTS MARKET, BY REGION
Comprehensive coverage of 9 Regions with country-level deep-dive of 14 Countries | 418 Data Tables.
 
 
 
 
 
225
 
13.1
INTRODUCTION
 
 
 
 
 
 
13.2
NORTH AMERICA
 
 
 
 
 
 
 
13.2.1
US
 
 
 
 
 
 
 
13.2.1.1
STRONG SUPPLEMENT PENETRATION AND RISING DEMAND FOR FUNCTIONAL NUTRITION
 
 
 
 
 
13.2.2
CANADA
 
 
 
 
 
 
 
13.2.2.1
GROWING DEMAND FOR NATURAL PRODUCTS SUPPORTS MARKET EXPANSION
 
 
 
 
 
13.2.3
MEXICO
 
 
 
 
 
 
 
13.2.3.1
EXPANDING PREVENTIVE NUTRITION DEMAND AND BROADENING SUPPLEMENT ECOSYSTEM
 
 
 
 
13.3
EUROPE
 
 
 
 
 
 
 
13.3.1
GERMANY
 
 
 
 
 
 
 
13.3.1.1
HIGH FOOD SUPPLEMENT PENETRATION AND DEMAND FOR MICRONUTRIENTS SUPPORT MARKET GROWTH
 
 
 
 
 
13.3.2
UK
 
 
 
 
 
 
 
13.3.2.1
ESTABLISHED FOOD SUPPLEMENT USE AND REGULATORY SUPPORT FOR INNOVATIVE INGREDIENTS SUPPORT MARKET GROWTH
 
 
 
 
 
13.3.3
FRANCE
 
 
 
 
 
 
 
13.3.3.1
ESTABLISHED SUPPLEMENT MARKET AND GROWING DEMAND FOR TARGETED NUTRITION SUPPORT MARKET GROWTH
 
 
 
 
 
13.3.4
ITALY
 
 
 
 
 
 
 
13.3.4.1
LARGE SUPPLEMENT PRODUCT BASE AND BROAD USE OF NUTRITIONAL INGREDIENTS SUPPORT MARKET GROWTH
 
 
 
 
 
13.3.5
SPAIN
 
 
 
 
 
 
 
13.3.5.1
ESTABLISHED SUPPLEMENT REGULATION AND BROAD NUTRITIONAL INGREDIENT APPLICATIONS SUPPORT MARKET GROWTH
 
 
 
 
 
13.3.6
REST OF EUROPE
 
 
 
 
 
 
 
13.3.6.1
EXPANDING FOOD SUPPLEMENT USE AND REGULATORY HARMONIZATION SUPPORT MARKET OPPORTUNITIES
 
 
 
 
13.4
ASIA PACIFIC
 
 
 
 
 
 
 
13.4.1
CHINA
 
 
 
 
 
 
 
13.4.1.1
EXPANDING HEALTH FOOD FORMULATION AND DIVERSIFICATION OF NUTRITIONAL PRODUCTS SUPPORT MARKET GROWTH
 
 
 
 
 
13.4.2
INDIA
 
 
 
 
 
 
 
13.4.2.1
LARGE AGRICULTURAL BASE AND EXPANDING NUTRACEUTICAL ECOSYSTEM SUPPORT MARKET GROWTH
 
 
 
 
 
13.4.3
JAPAN
 
 
 
 
 
 
 
13.4.3.1
RAPID POPULATION AGING AND PREVENTIVE HEALTHCARE CULTURE DRIVE DEMAND FOR FUNCTIONAL INGREDIENTS
 
 
 
 
 
13.4.4
AUSTRALIA & NEW ZEALAND
 
 
 
 
 
 
 
13.4.4.1
STRONG SUPPLEMENT ADOPTION AND EXPORT-ORIENTED HEALTH PRODUCT ECOSYSTEM SUPPORT NUTRACEUTICAL INGREDIENT DEMAND
 
 
 
 
 
13.4.5
REST OF ASIA PACIFIC
 
 
 
 
 
13.5
SOUTH AMERICA
 
 
 
 
 
 
 
13.5.1
BRAZIL
 
 
 
 
 
 
 
13.5.1.1
STRONG SUPPLEMENT PENETRATION AND RAPID EXPANSION OF PROTEIN AND VITAMIN INGREDIENTS
 
 
 
 
 
13.5.2
ARGENTINA
 
 
 
 
 
 
 
13.5.2.1
GROWING DEMAND FOR TARGETED NUTRITION AND SPECIALTY NUTRACEUTICAL INGREDIENTS
 
 
 
 
 
13.5.3
REST OF SOUTH AMERICA
 
 
 
 
 
 
 
13.5.3.1
EMERGING CONSUMER AWARENESS AND DIVERSIFICATION OF FUNCTIONAL NUTRITION
 
 
 
 
13.6
REST OF THE WORLD (ROW)
 
 
 
 
 
 
 
13.6.1
MIDDLE EAST
 
 
 
 
 
 
 
13.6.1.1
RISING NUTRITION-RELATED HEALTH NEEDS AND PREVENTIVE HEALTHCARE FOCUS
 
 
 
 
 
13.6.2
AFRICA
 
 
 
 
 
 
 
13.6.2.1
NUTRITIONAL NEEDS AND FOOD FORTIFICATION PROGRAMS CREATE STRUCTURAL INGREDIENT DEMAND
 
 
 
14
COMPETITIVE LANDSCAPE
Gain strategic insights from key players and emerging leaders in the nutraceutical ingredients market.
 
 
 
 
 
398
 
14.1
OVERVIEW
 
 
 
 
 
 
14.2
KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021–2026
 
 
 
 
 
 
14.3
BRAND/PRODUCT COMPARISON
 
 
 
 
 
 
 
 
14.3.1
CARGILL, INCORPORATED (EPICOR)
 
 
 
 
 
 
14.3.2
ADM (FIBERSOL)
 
 
 
 
 
 
14.3.3
GLANBIA PLC (FERRIUP)
 
 
 
 
 
 
14.3.4
DSM-FIRMENICH (PEPTOPRO)
 
 
 
 
 
 
14.3.5
ROQUETTE FRÈRES (NUTRALYS)
 
 
 
 
 
14.4
REVENUE ANALYSIS, 2023–2025
 
 
 
 
 
 
 
14.5
COMPANY VALUATION AND FINANCIAL METRICS
 
 
 
 
 
 
 
14.5.1
COMPANY VALUATION
 
 
 
 
 
 
14.5.2
EV/EBITDA
 
 
 
 
 
14.6
MARKET SHARE ANALYSIS, 2025
 
 
 
 
 
 
 
14.7
NUTRACEUTICAL INGREDIENTS MARKET COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
 
 
 
 
 
 
 
 
14.7.1
STARS
 
 
 
 
 
 
14.7.2
EMERGING LEADERS
 
 
 
 
 
 
14.7.3
PERVASIVE PLAYERS
 
 
 
 
 
 
14.7.4
PARTICIPANTS
 
 
 
 
 
 
14.7.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
 
 
 
 
 
 
 
14.7.5.1
COMPANY FOOTPRINT
 
 
 
 
 
 
14.7.5.2
REGION FOOTPRINT
 
 
 
 
 
 
14.7.5.3
INGREDIENT TYPE FOOTPRINT
 
 
 
 
 
 
14.7.5.4
SOURCE FOOTPRINT
 
 
 
 
 
 
14.7.5.5
APPLICATION FOOTPRINT
 
 
 
 
14.8
COMPANY EVALUATION MATRIX: START-UPS/SMES, 2025
 
 
 
 
 
 
 
 
14.8.1
PROGRESSIVE COMPANIES
 
 
 
 
 
 
14.8.2
RESPONSIVE COMPANIES
 
 
 
 
 
 
14.8.3
DYNAMIC COMPANIES
 
 
 
 
 
 
14.8.4
STARTING BLOCKS
 
 
 
 
 
 
14.8.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
 
 
 
 
 
 
 
14.8.5.1
KEY STARTUPS/SMES
 
 
 
 
 
 
14.8.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
 
 
14.9
COMPETITIVE SCENARIO
 
 
 
 
 
 
 
14.9.1
PRODUCT LAUNCHES
 
 
 
 
 
 
14.9.2
DEALS
 
 
 
 
 
 
14.9.3
EXPANSIONS
 
 
 
 
15
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
 
 
425
 
15.1
KEY PLAYERS
 
 
 
 
 
 
 
15.1.1
CARGILL, INCORPORATED
 
 
 
 
 
 
 
15.1.1.1
BUSINESS OVERVIEW
 
 
 
 
 
 
15.1.1.2
PRODUCTS OFFERED
 
 
 
 
 
 
15.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
 
 
 
 
15.1.1.3.1
PRODUCT LAUNCHES
 
 
 
 
 
 
15.1.1.3.2
DEALS
 
 
 
 
 
 
15.1.1.3.3
EXPANSIONS
 
 
 
 
 
 
15.1.1.3.4
OTHER DEVELOPMENTS
 
 
 
 
15.1.1.4
MNM VIEW
 
 
 
 
 
 
 
 
15.1.1.4.1
RIGHT TO WIN
 
 
 
 
 
 
15.1.1.4.2
STRATEGIC CHOICES
 
 
 
 
 
 
15.1.1.4.3
WEAKNESSES AND COMPETITIVE THREATS
 
 
 
15.1.2
ADM
 
 
 
 
 
 
15.1.3
INTERNATIONAL FLAVORS & FRAGRANCES INC.
 
 
 
 
 
 
15.1.4
BASF
 
 
 
 
 
 
15.1.5
GLANBIA PLC
 
 
 
 
 
 
15.1.6
ARLA FOODS AMBA
 
 
 
 
 
 
15.1.7
DSM-FIRMENICH
 
 
 
 
 
 
15.1.8
INGREDION
 
 
 
 
 
 
15.1.9
TATE & LYLE
 
 
 
 
 
 
15.1.10
ROQUETTE FRÈRES
 
 
 
 
 
 
15.1.11
ASSOCIATED BRITISH FOODS PLC
 
 
 
 
 
 
15.1.12
FONTERRA CO-OPERATIVE GROUP LIMITED
 
 
 
 
 
 
15.1.13
KERRY GROUP PLC
 
 
 
 
 
 
15.1.14
NOVONESIS GROUP
 
 
 
 
 
 
15.1.15
BALCHEM CORP.
 
 
 
 
 
15.2
OTHER PLAYERS
 
 
 
 
 
 
 
15.2.1
AJINOMOTO CO., INC.
 
 
 
 
 
 
15.2.2
DIVI'S LABORATORIES LIMITED
 
 
 
 
 
 
15.2.3
KEMIN INDUSTRIES, INC.
 
 
 
 
 
 
15.2.4
GELITA
 
 
 
 
 
 
15.2.5
BENEO
 
 
 
 
 
 
15.2.6
COSUCRA
 
 
 
 
 
 
15.2.7
CONAGEN, INC.
 
 
 
 
 
 
15.2.8
SARSHIKA PHARMACHEM LLP
 
 
 
 
 
 
15.2.9
CANURTA NATURALS USA
 
 
 
 
 
 
15.2.10
EVANIUM
 
 
 
 
16
RESEARCH METHODOLOGY
 
 
 
 
 
601
 
16.1
RESEARCH DATA
 
 
 
 
 
 
 
16.1.1
SECONDARY DATA
 
 
 
 
 
 
 
16.1.1.1
LIST OF MAJOR SECONDARY SOURCES
 
 
 
 
 
 
16.1.1.2
KEY DATA FROM SECONDARY SOURCES
 
 
 
 
 
16.1.2
PRIMARY DATA
 
 
 
 
 
 
 
16.1.2.1
KEY DATA FROM PRIMARY SOURCES
 
 
 
 
 
 
16.1.2.2
KEY INDUSTRY INSIGHTS
 
 
 
 
 
 
16.1.2.3
BREAKDOWN OF PRIMARIES
 
 
 
 
16.2
MARKET SIZE ESTIMATION
 
 
 
 
 
 
 
16.2.1
BOTTOM-UP APPROACH
 
 
 
 
 
 
16.2.2
TOP-DOWN APPROACH
 
 
 
 
 
 
 
16.2.2.1
APPROACH TO ESTIMATE MARKET SIZE USING TOP-DOWN ANALYSIS
 
 
 
 
 
16.2.3
SUPPLY-SIDE ANALYSIS
 
 
 
 
 
 
16.2.4
DEMAND-SIDE ANALYSIS
 
 
 
 
 
16.3
DATA TRIANGULATION
 
 
 
 
 
 
16.4
RESEARCH ASSUMPTIONS
 
 
 
 
 
 
16.5
RESEARCH LIMITATIONS AND RISK ASSESSMENT
 
 
 
 
 
17
ADJACENT & RELATED MARKETS
 
 
 
 
 
612
 
17.1
INTRODUCTION
 
 
 
 
 
 
17.2
LIMITATIONS
 
 
 
 
 
 
17.3
PROTEIN INGREDIENTS MARKET
 
 
 
 
 
 
 
17.3.1
MARKET DEFINITION
 
 
 
 
 
 
17.3.2
MARKET OVERVIEW
 
 
 
 
 
17.4
NUTRACEUTICAL GUMMIES MARKET
 
 
 
 
 
 
 
17.4.1
MARKET DEFINITION
 
 
 
 
 
 
17.4.2
MARKET OVERVIEW
 
 
 
 
18
APPENDIX
 
 
 
 
 
617
 
18.1
DISCUSSION GUIDE
 
 
 
 
 
 
18.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
 
 
18.3
CUSTOMIZATION OPTIONS
 
 
 
 
 
 
18.4
RELATED REPORTS
 
 
 
 
 
 
18.5
AUTHOR DETAILS
 
 
 
 
 
LIST OF TABLES
 
 
 
 
 
 
 
TABLE 1
USD EXCHANGE RATES, 2021–2025
 
 
 
 
 
 
TABLE 2
NUTRACEUTICAL INGREDIENTS MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
TABLE 3
NUTRACEUTICAL INGREDIENTS MARKET: SUPPLY CHAIN (ECOSYSTEM)
 
 
 
 
 
 
TABLE 4
AVERAGE SELLING PRICE (ASP), BY INGREDIENT TYPE, 2022–2025 (USD/KG)
 
 
 
 
 
 
TABLE 5
AVERAGE SELLING PRICE (ASP), BY REGION, 2022–2025 (USD/KG)
 
 
 
 
 
 
TABLE 6
TOP 10 EXPORTERS OF HS CODE 2936, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 7
TOP 10 EXPORTERS OF HS CODE 2936, 2021–2025 (K TONS)
 
 
 
 
 
 
TABLE 8
TOP 10 EXPORTERS OF HS CODE 2936, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 9
TOP 10 IMPORTERS OF HS CODE 2936, 2021–2025 (K TONS)
 
 
 
 
 
 
TABLE 10
NUTRACEUTICAL INGREDIENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2026–2027
 
 
 
 
 
 
TABLE 11
TARIFF IMPACT ON END-USE INDUSTRIES: NUTRACEUTICAL INGREDIENTS MARKET
 
 
 
 
 
 
TABLE 16
INTERNATIONAL: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 17
GLOBAL INDUSTRY STANDARDS IN NUTRACEUTICAL INGREDIENTS MARKET
 
 
 
 
 
 
TABLE 18
SUSTAINABILITY INITIATIVES IN NUTRACEUTICAL INGREDIENTS MARKET
 
 
 
 
 
 
TABLE 19
IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
 
 
 
 
 
 
TABLE 20
CERTIFICATION FOR NUTRACEUTICAL INGREDIENTS MARKET
 
 
 
 
 
 
TABLE 21
LABELING FOR NUTRACEUTICAL INGREDIENTS MARKET
 
 
 
 
 
 
TABLE 22
ECO-STANDARDS FOR NUTRACEUTICAL INGREDIENTS MARKET
 
 
 
 
 
 
TABLE 23
LIST OF MAJOR PATENTS IN NUTRACEUTICAL INGREDIENTS MARKET, 2021–2026
 
 
 
 
 
 
TABLE 24
TOP USE CASES AND MARKET POTENTIAL
 
 
 
 
 
 
TABLE 25
BEST PRACTICES: COMPANIES IMPLEMENTING USE CASES
 
 
 
 
 
 
TABLE 26
NUTRACEUTICAL INGREDIENTS MARKET: CASE STUDIES RELATED TO GEN AI IMPLEMENTATION
 
 
 
 
 
 
TABLE 27
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
 
 
 
 
 
 
TABLE 28
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY APPLICATION
 
 
 
 
 
 
TABLE 29
KEY BUYING CRITERIA, BY APPLICATION
 
 
 
 
 
 
TABLE 30
UNMET NEEDS IN NUTRACEUTICAL INGREDIENTS MARKET, BY END-USE INDUSTRY
 
 
 
 
 
 
TABLE 31
NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 32
NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 33
NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 34
NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 35
FUNCTIONAL PROTEINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 36
FUNCTIONAL PROTEINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 37
FUNCTIONAL PROTEINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 38
FUNCTIONAL PROTEINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 39
OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 40
OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 41
OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 42
OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 43
PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 44
PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 45
PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 46
PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 47
PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 48
PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 49
PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 50
PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 51
FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 52
FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 53
FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 54
FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 55
VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 56
VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 57
VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 58
VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 59
VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 60
VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 61
VITAMIN A: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 62
VITAMIN A: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 63
VITAMIN B: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 64
VITAMIN B: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 65
VITAMIN C: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 66
VITAMIN C: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 67
VITAMIN D: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 68
VITAMIN D: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 69
VITAMIN E: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 70
VITAMIN E: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 71
OTHER VITAMINS (MULTIVITAMIN, ETC.): NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 72
OTHER VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 73
MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 74
MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 75
MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 76
MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 77
MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 78
MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 79
CALCIUM: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 80
CALCIUM: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 81
MAGNESIUM: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 82
MAGNESIUM: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 83
IRON: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 84
IRON: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 85
ZINC: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 86
ZINC: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 87
OTHER MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 88
OTHER MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 89
AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 90
AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 91
AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 92
AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 93
AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 94
AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 95
BRANCHED-CHAIN AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 96
BRANCHED-CHAIN AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 97
ESSENTIAL AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 98
ESSENTIAL AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 99
NON-ESSENTIAL AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 100
NON-ESSENTIAL AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 101
SPECIALTY AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 102
SPECIALTY AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 103
CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 104
CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 105
CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 106
CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 107
OTHER INGREDIENT TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 108
OTHER INGREDIENT TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 109
OTHER INGREDIENT TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 110
OTHER INGREDIENT TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 111
NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 112
NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 113
PLANT-BASED: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 114
PLANT-BASED: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 115
ANIMAL-BASED: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 116
ANIMAL-BASED: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 117
MICROBIAL-BASED: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 118
MICROBIAL-BASED: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 119
SYNTHETICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 120
SYNTHETICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 121
NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 122
NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 123
HUMAN NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 124
HUMAN NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 125
HUMAN NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 126
HUMAN NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 127
DIETARY SUPPLEMENTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 128
DIETARY SUPPLEMENTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 129
FUNCTIONAL FOODS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 130
FUNCTIONAL FOODS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 131
FUNCTIONAL BEVERAGES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 132
FUNCTIONAL BEVERAGES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 133
MEDICAL & SPECIALIZED NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 134
MEDICAL & SPECIALIZED NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 135
INFANT & EARLY-LIFE NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 136
INFANT & EARLY-LIFE NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 137
ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 138
ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 139
ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 140
ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 141
COMPANION ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 142
COMPANION ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 143
LIVESTOCK NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 144
LIVESTOCK NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 145
AQUACULTURE NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 146
AQUACULTURE NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 147
OTHER ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 148
OTHER ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 149
NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 150
NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 151
NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 152
NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 153
NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 154
NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 155
NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 156
NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 157
NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 158
NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 159
NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 160
NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 161
NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 162
NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 163
NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 164
NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 165
NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 166
NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 167
NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 168
NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 169
NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 170
NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 171
NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 172
NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 173
NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 174
NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 175
US: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 176
US: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 177
US: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 178
US: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 179
US: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 180
US: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 181
US: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 182
US: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 183
US: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 184
US: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 185
US: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 186
US: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 187
US: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 188
US: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 189
US: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 190
US: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 191
CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 192
CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 193
CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 194
CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 195
CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 196
CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 197
CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 198
CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 199
CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 200
CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 201
CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 202
CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 203
CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 204
CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 205
CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 206
CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 207
MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 208
MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 209
MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 210
MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 211
MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 212
MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 213
MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 214
MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 215
MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 216
MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 217
MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 218
MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 219
MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 220
MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 221
MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 222
MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 223
EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 224
EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 225
EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 226
EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 227
EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 228
EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 229
EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 230
EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 231
EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 232
EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 233
EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 234
EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 235
EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 236
EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 237
EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 238
EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 239
EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 240
EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 241
EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 242
EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 243
EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 244
EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 245
GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 246
GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 247
GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 248
GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 249
GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 250
GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 251
GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 252
GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 253
GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 254
GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 255
GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 256
GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 257
GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 258
GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 259
GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 260
GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 261
UK: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 262
UK: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 263
UK: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 264
UK: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 265
UK: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 266
UK: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 267
UK: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 268
UK: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 269
UK: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 270
UK: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 271
UK: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 272
UK: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 273
UK: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 274
UK: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 275
UK: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 276
UK: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 277
FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 278
FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 279
FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 280
FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 281
FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 282
FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 283
FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 284
FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 285
FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 286
FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 287
FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 288
FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 289
FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 290
FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 291
FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 292
FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 293
ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 294
ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 295
ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 296
ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 297
ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 298
ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 299
ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 300
ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 301
ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 302
ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 303
ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 304
ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 305
ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 306
ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 307
ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 308
ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 309
SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 310
SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 311
SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 312
SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 313
SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 314
SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 315
SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 316
SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 317
SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 318
SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 319
SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 320
SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 321
SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 322
SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 323
SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 324
SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 325
REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 326
REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 327
REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 328
REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 329
REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 330
REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 331
REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 332
REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 333
REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 334
REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 335
REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 336
REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 337
REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 338
REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 339
REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 340
REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 341
ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 342
ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 343
ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 344
ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 345
ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 346
ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 347
ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 348
ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 349
ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 350
ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 351
ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 352
ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 353
ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 354
ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 355
ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 356
ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 357
ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 358
ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 359
ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 360
ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 361
ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 362
ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 363
CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 364
CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 365
CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 366
CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 367
CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 368
CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 369
CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 370
CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 371
CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 372
CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 373
CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 374
CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 375
CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 376
CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 377
CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 378
CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 379
INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 380
INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 381
INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 382
INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 383
INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 384
INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 385
INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 386
INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 387
INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 388
INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 389
INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 390
INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 391
INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 392
INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 393
INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 394
INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 395
JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 396
JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 397
JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 398
JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 399
JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 400
JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 401
JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 402
JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 403
JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 404
JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 405
JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 406
JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 407
JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 408
JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 409
JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 410
JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 411
AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 412
AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 413
AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 414
AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 415
AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 416
AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 417
AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 418
AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 419
AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 420
AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 421
AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 422
AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 423
AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 424
AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 425
AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 426
AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 427
REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 428
REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 429
REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 430
REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 431
REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 432
REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 433
REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 434
REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 435
REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 436
REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 437
REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 438
REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 439
REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 440
REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 441
REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 442
REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 443
SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 444
SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 445
SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 446
SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 447
SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 448
SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 449
SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 450
SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 451
SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 452
SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 453
SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 454
SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 455
SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 456
SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 457
SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 458
SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 459
SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 460
SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 461
SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 462
SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 463
SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 464
SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 465
BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 466
BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 467
BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 468
BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 469
BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 470
BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 471
BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 472
BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 473
BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 474
BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 475
BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 476
BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 477
BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 478
BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 479
BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 480
BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 481
ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 482
ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 483
ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 484
ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 485
ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 486
ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 487
ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 488
ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 489
ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 490
ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 491
ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 492
ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 493
ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 494
ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 495
ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 496
ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 497
REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 498
REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 499
REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 500
REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 501
REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 502
REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 503
REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 504
REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 505
REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 506
REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 507
REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 508
REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 509
REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 510
REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 511
REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 512
REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 513
ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 514
ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 515
ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 516
ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 517
ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 518
ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 519
ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 520
ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 521
ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 522
ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 523
ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 524
ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 525
ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 526
ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 527
ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 528
ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 529
ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 530
ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 531
ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 532
ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 533
ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 534
ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 535
MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 536
MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 537
MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 538
MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 539
MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 540
MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 541
MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 542
MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 543
MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 544
MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 545
MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 546
MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 547
MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 548
MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 549
MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 550
MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 551
AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 552
AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 553
AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 554
AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 555
AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 556
AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 557
AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 558
AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 559
AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 560
AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 561
AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 562
AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 563
AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 564
AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 565
AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 566
AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 567
COMPETITIVE STRATEGIES INITIATIVES IN NUTRACEUTICAL INGREDIENTS MARKET
 
 
 
 
 
 
TABLE 568
NUTRACEUTICAL INGREDIENTS MARKET: DEGREE OF COMPETITION
 
 
 
 
 
 
TABLE 569
NUTRACEUTICAL INGREDIENTS MARKET: REGION FOOTPRINT
 
 
 
 
 
 
TABLE 570
NUTRACEUTICAL INGREDIENTS MARKET: INGREDIENT TYPE FOOTPRINT
 
 
 
 
 
 
TABLE 571
NUTRACEUTICAL INGREDIENTS MARKET: SOURCE FOOTPRINT
 
 
 
 
 
 
TABLE 572
NUTRACEUTICAL INGREDIENTS MARKET: APPLICATION FOOTPRINT
 
 
 
 
 
 
TABLE 573
NUTRACEUTICAL INGREDIENTS MARKET: KEY STARTUPS/SMES
 
 
 
 
 
 
TABLE 574
NUTRACEUTICAL INGREDIENTS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2025
 
 
 
 
 
 
TABLE 575
NUTRACEUTICAL INGREDIENTS MARKET: PRODUCT LAUNCHES, 2021–AUGUST 2026
 
 
 
 
 
 
TABLE 576
NUTRACEUTICAL INGREDIENTS MARKET: DEALS, 2021–AUGUST 2026
 
 
 
 
 
 
TABLE 577
NUTRACEUTICAL INGREDIENTS MARKET: EXPANSIONS, 2021–AUGUST 2026
 
 
 
 
 
 
TABLE 578
CARGILL, INCORPORATED: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 579
CARGILL, INCORPORATED: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 580
CARGILL, INCORPORATED: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 581
CARGILL, INCORPORATED: DEALS
 
 
 
 
 
 
TABLE 582
CARGILL, INCORPORATED: EXPANSIONS
 
 
 
 
 
 
TABLE 583
CARGILL, INCORPORATED: OTHER DEVELOPMENTS
 
 
 
 
 
 
TABLE 584
ADM: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 585
ADM: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 586
ADM: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 587
ADM: DEALS
 
 
 
 
 
 
TABLE 588
ADM: EXPANSIONS
 
 
 
 
 
 
TABLE 589
ADM: OTHER DEVELOPMENTS
 
 
 
 
 
 
TABLE 590
INTERNATIONAL FLAVORS & FRAGRANCES INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 591
INTERNATIONAL FLAVORS & FRAGRANCES INC.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 592
INTERNATIONAL FLAVORS & FRAGRANCES INC.: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 593
INTERNATIONAL FLAVORS & FRAGRANCES INC.: DEALS
 
 
 
 
 
 
TABLE 594
INTERNATIONAL FLAVORS & FRAGRANCES INC.: EXPANSIONS
 
 
 
 
 
 
TABLE 595
INTERNATIONAL FLAVORS & FRAGRANCES INC.: OTHER DEVELOPMENTS
 
 
 
 
 
 
TABLE 596
BASF: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 597
BASF: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 598
BASF: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 599
BASF: DEALS
 
 
 
 
 
 
TABLE 600
BASF: EXPANSIONS
 
 
 
 
 
 
TABLE 601
BASF: OTHER DEVELOPMENTS
 
 
 
 
 
 
TABLE 602
GLANBIA PLC: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 603
GLANBIA PLC: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 604
GLANBIA PLC: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 605
GLANBIA PLC: DEALS
 
 
 
 
 
 
TABLE 606
GLANBIA PLC: EXPANSIONS
 
 
 
 
 
 
TABLE 607
GLANBIA PLC: OTHER DEVELOPMENTS
 
 
 
 
 
 
TABLE 608
ARLA FOODS AMBA: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 609
ARLA FOODS AMBA: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 610
ARLA FOODS AMBA: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 611
ARLA FOODS AMBA: DEALS
 
 
 
 
 
 
TABLE 612
ARLA FOODS AMBA: EXPANSIONS
 
 
 
 
 
 
TABLE 613
ARLA FOODS AMBA: OTHER DEVELOPMENTS
 
 
 
 
 
 
TABLE 614
DSM-FIRMENICH: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 615
DSM-FIRMENICH: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 616
DSM-FIRMENICH: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 617
DSM-FIRMENICH: DEALS
 
 
 
 
 
 
TABLE 618
DSM-FIRMENICH: EXPANSIONS
 
 
 
 
 
 
TABLE 619
DSM-FIRMENICH: OTHER DEVELOPMENTS
 
 
 
 
 
 
TABLE 620
INGREDION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 621
INGREDION: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 622
INGREDION: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 623
INGREDION: DEALS
 
 
 
 
 
 
TABLE 624
INGREDION: EXPANSIONS
 
 
 
 
 
 
TABLE 625
INGREDION: OTHER DEVELOPMENTS
 
 
 
 
 
 
TABLE 626
TATE & LYLE: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 627
TATE & LYLE: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 628
TATE & LYLE: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 629
TATE & LYLE: DEALS
 
 
 
 
 
 
TABLE 630
TATE & LYLE: EXPANSIONS
 
 
 
 
 
 
TABLE 631
TATE & LYLE: OTHER DEVELOPMENTS
 
 
 
 
 
 
TABLE 632
ROQUETTE FRÈRES: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 633
ROQUETTE FRÈRES: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 634
ROQUETTE FRÈRES: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 635
ROQUETTE FRÈRES: DEALS
 
 
 
 
 
 
TABLE 636
ROQUETTE FRÈRES: EXPANSIONS
 
 
 
 
 
 
TABLE 637
ROQUETTE FRÈRES: OTHER DEVELOPMENTS
 
 
 
 
 
 
TABLE 638
ASSOCIATED BRITISH FOODS PLC: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 639
ASSOCIATED BRITISH FOODS PLC: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 640
ASSOCIATED BRITISH FOODS PLC: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 641
ASSOCIATED BRITISH FOODS PLC: DEALS
 
 
 
 
 
 
TABLE 642
ASSOCIATED BRITISH FOODS PLC: EXPANSIONS
 
 
 
 
 
 
TABLE 643
ASSOCIATED BRITISH FOODS PLC: OTHER DEVELOPMENTS
 
 
 
 
 
 
TABLE 644
FONTERRA CO-OPERATIVE GROUP LIMITED: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 645
FONTERRA CO-OPERATIVE GROUP LIMITED: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 646
FONTERRA CO-OPERATIVE GROUP LIMITED: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 647
FONTERRA CO-OPERATIVE GROUP LIMITED: DEALS
 
 
 
 
 
 
TABLE 648
FONTERRA CO-OPERATIVE GROUP LIMITED: EXPANSIONS
 
 
 
 
 
 
TABLE 649
FONTERRA CO-OPERATIVE GROUP LIMITED: OTHER DEVELOPMENTS
 
 
 
 
 
 
TABLE 650
KERRY GROUP PLC: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 651
KERRY GROUP PLC: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 652
KERRY GROUP PLC: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 653
KERRY GROUP PLC: DEALS
 
 
 
 
 
 
TABLE 654
KERRY GROUP PLC: EXPANSIONS
 
 
 
 
 
 
TABLE 655
KERRY GROUP PLC: OTHER DEVELOPMENTS
 
 
 
 
 
 
TABLE 656
NOVONESIS GROUP: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 657
NOVONESIS GROUP: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 658
NOVONESIS GROUP: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 659
NOVONESIS GROUP: DEALS
 
 
 
 
 
 
TABLE 660
NOVONESIS GROUP: EXPANSIONS
 
 
 
 
 
 
TABLE 661
NOVONESIS GROUP: OTHER DEVELOPMENTS
 
 
 
 
 
 
TABLE 662
BALCHEM CORP.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 663
BALCHEM CORP.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 664
BALCHEM CORP.: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 665
BALCHEM CORP.: DEALS
 
 
 
 
 
 
TABLE 666
BALCHEM CORP.: EXPANSIONS
 
 
 
 
 
 
TABLE 667
BALCHEM CORP.: OTHER DEVELOPMENTS
 
 
 
 
 
 
TABLE 668
AJINOMOTO CO., INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 669
AJINOMOTO CO., INC.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 670
AJINOMOTO CO., INC.: DEALS
 
 
 
 
 
 
TABLE 671
AJINOMOTO CO., INC.: EXPANSIONS
 
 
 
 
 
 
TABLE 672
AJINOMOTO CO., INC.: OTHER DEVELOPMENTS
 
 
 
 
 
 
TABLE 673
DIVI'S LABORATORIES LIMITED: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 674
DIVI'S LABORATORIES LIMITED: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 675
DIVI'S LABORATORIES LIMITED: DEALS
 
 
 
 
 
 
TABLE 676
DIVI'S LABORATORIES LIMITED: EXPANSIONS
 
 
 
 
 
 
TABLE 677
KEMIN INDUSTRIES, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 678
KEMIN INDUSTRIES, INC.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 679
KEMIN INDUSTRIES, INC.: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 680
KEMIN INDUSTRIES, INC.: DEALS
 
 
 
 
 
 
TABLE 681
KEMIN INDUSTRIES, INC.: OTHER DEVELOPMENTS
 
 
 
 
 
 
TABLE 682
GELITA: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 683
GELITA: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 684
GELITA: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 685
GELITA: DEALS
 
 
 
 
 
 
TABLE 686
GELITA: EXPANSIONS
 
 
 
 
 
 
TABLE 687
GELITA: OTHER DEVELOPMENTS
 
 
 
 
 
 
TABLE 688
BENEO: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 689
BENEO: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 690
BENEO: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 691
BENEO: DEALS
 
 
 
 
 
 
TABLE 692
BENEO: EXPANSIONS
 
 
 
 
 
 
TABLE 693
BENEO: OTHER DEVELOPMENTS
 
 
 
 
 
 
TABLE 694
COSUCRA: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 695
CONAGEN, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 696
SARSHIKA PHARMACHEM LLP: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 697
CANURTA NATURALS USA: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 698
EVANIUM: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 699
ADJACENT MARKETS TO NUTRACEUTICAL INGREDIENTS MARKET
 
 
 
 
 
 
TABLE 700
PROTEIN INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 701
PROTEIN INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 702
PROTEIN INGREDIENTS MARKET, BY REGION, 2022–2025 (TONS)
 
 
 
 
 
 
TABLE 703
PROTEIN INGREDIENTS MARKET, BY REGION, 2026–2031 (TONS)
 
 
 
 
 
 
TABLE 704
NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 705
NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
 
 
FIGURE 1
MARKET SEGMENTATION
 
 
 
 
 
 
FIGURE 2
MARKET SCENARIO
 
 
 
 
 
 
FIGURE 3
NUTRACEUTICAL INGREDIENTS MARKET, 2022–2031
 
 
 
 
 
 
FIGURE 4
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN NUTRACEUTICAL INGREDIENTS MARKET, 2021–JUNE 2026
 
 
 
 
 
 
FIGURE 5
DISRUPTIONS INFLUENCING GROWTH NUTRACEUTICAL INGREDIENTS MARKET
 
 
 
 
 
 
FIGURE 6
NUTRACEUTICAL INGREDIENTS MARKET: HIGH-GROWTH SEGMENTS, 2026–2031
 
 
 
 
 
 
FIGURE 7
ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 8
GROWING DEMAND FOR TARGETED NUTRITION AND FUNCTIONAL INGREDIENTS TO DRIVE MARKET GROWTH
 
 
 
 
 
 
FIGURE 9
FUNCTIONAL PROTEINS SEGMENT AND ASIA PACIFIC TO ACCOUNT FOR LARGEST MARKET SHARES IN 2026
 
 
 
 
 
 
FIGURE 10
PLANT-BASED SEGMENT TO LEAD MARKET IN 2026
 
 
 
 
 
 
FIGURE 11
FUNCTIONAL PROTEINS SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026
 
 
 
 
 
 
FIGURE 12
HUMAN NUTRITION SEGMENT TO DOMINATE MARKET IN 2026
 
 
 
 
 
 
FIGURE 13
US TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026
 
 
 
 
 
 
FIGURE 14
NUTRACEUTICAL INGREDIENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
 
 
FIGURE 15
SOURCES USED TO CONSUME SELECTED NUTRIENTS
 
 
 
 
 
 
FIGURE 16
NUTRACEUTICAL INGREDIENTS MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
FIGURE 17
GLOBAL CURRENT HEALTH EXPENDITURE AS A SHARE OF GDP, 2000–2023 (%)
 
 
 
 
 
 
FIGURE 18
REAL HOUSEHOLD INCOME PER CAPITA GROWTH IN OECD, Q2 2023–Q2 2025 (%)
 
 
 
 
 
 
FIGURE 20
NUTRACEUTICAL INGREDIENTS MARKET: MARKET MAP
 
 
 
 
 
 
FIGURE 21
AVERAGE SELLING PRICE TREND, BY INGREDIENT TYPE, 2022-2025 (USD/KG)
 
 
 
 
 
 
FIGURE 22
AVERAGE SELLING PRICE TREND, BY REGION (USD/KG)
 
 
 
 
 
 
FIGURE 23
EXPORT VALUE OF HS CODE 2936, BY KEY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
FIGURE 24
IMPORT VALUE OF HS CODE 2936, BY KEY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
FIGURE 25
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESS
 
 
 
 
 
 
FIGURE 26
INVESTMENT AND FUNDING SCENARIO, 2021–2026 (USD MILLION)
 
 
 
 
 
 
FIGURE 27
NUMBER OF PATENTS GRANTED FOR NUTRACEUTICAL INGREDIENTS MARKET, 2016–2026
 
 
 
 
 
 
FIGURE 28
REGIONAL ANALYSIS OF PATENTS GRANTED FOR NUTRACEUTICAL INGREDIENTS MARKET, 2016–2026
 
 
 
 
 
 
FIGURE 29
FUTURE APPLICATIONS
 
 
 
 
 
 
FIGURE 31
KEY BUYING CRITERIA FOR APPLICATION
 
 
 
 
 
 
FIGURE 32
ADOPTION BARRIERS AND INTERNAL CHALLENGES
 
 
 
 
 
 
FIGURE 33
NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026 VS. 2031
 
 
 
 
 
 
FIGURE 34
NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE, 2026 VS. 2031
 
 
 
 
 
 
 
NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
 
 
 
 
 
 
2026
VS. 2031 (USD MILLION)
 
 
 
 
 
211
FIGURE 36
INDIA TO RECORD FASTEST GROWTH DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 37
NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 38
ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 39
BRAND/PRODUCT COMPARISON
 
 
 
 
 
 
FIGURE 40
NUTRACEUTICAL INGREDIENTS MARKET: REVENUE ANALYSIS FOR FIVE KEY PLAYERS, 2023–2025 (USD BILLION)
 
 
 
 
 
 
FIGURE 41
COMPANY VALUATION OF NUTRACEUTICAL INGREDIENTS PLAYERS
 
 
 
 
 
 
FIGURE 42
EV/EBITDA OF KEY COMPANIES
 
 
 
 
 
 
FIGURE 43
SHARE OF LEADING COMPANIES IN NUTRACEUTICAL INGREDIENTS MARKET, 2025
 
 
 
 
 
 
FIGURE 44
NUTRACEUTICAL INGREDIENTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
 
 
 
 
 
 
FIGURE 45
NUTRACEUTICAL INGREDIENTS MARKET: COMPANY FOOTPRINT
 
 
 
 
 
 
FIGURE 46
NUTRACEUTICAL INGREDIENTS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
 
 
 
 
 
 
FIGURE 47
CARGILL, INCORPORATED: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 48
ADM: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 49
INTERNATIONAL FLAVORS & FRAGRANCES INC.: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 50
BASF: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 51
GLANBIA PLC: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 52
ARLA FOODS AMBA: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 53
DSM-FIRMENICH: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 54
INGREDION: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 55
TATE & LYLE: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 56
ROQUETTE FRÈRES: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 57
ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 58
FONTERRA CO-OPERATIVE GROUP LIMITED: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 59
KERRY GROUP PLC: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 60
NOVONESIS GROUP: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 61
BALCHEM CORP.: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 62
AJINOMOTO CO., INC.: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 63
DIVI'S LABORATORIES LIMITED: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 64
NUTRACEUTICAL INGREDIENTS MARKET: RESEARCH DESIGN
 
 
 
 
 
 
FIGURE 65
KEY DATA FROM SECONDARY SOURCES
 
 
 
 
 
 
FIGURE 66
KEY DATA FROM PRIMARY SOURCES
 
 
 
 
 
 
FIGURE 67
INSIGHTS FROM INDUSTRY EXPERTS
 
 
 
 
 
 
FIGURE 68
BREAKDOWN OF PRIMARIES, BY COMPANY TYPE, DESIGNATION, AND REGION
 
 
 
 
 
 
FIGURE 69
NUTRACEUTICAL INGREDIENTS MARKET: BOTTOM-UP APPROACH
 
 
 
 
 
 
FIGURE 70
MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
 
 
 
 
 
 
FIGURE 71
MARKET SIZE ESTIMATION METHODOLOGY: SUPPLY-SIDE ANALYSIS
 
 
 
 
 
 
FIGURE 72
MARKET SIZE ESTIMATION METHODOLOGY: DEMAND-SIDE ANALYSIS
 
 
 
 
 
 
FIGURE 73
DATA TRIANGULATION METHODOLOGY
 
 
 
 
 
 

 

Methodology

This study employed two primary approaches to estimate the current size of the nutraceutical ingredients market. Exhaustive secondary research was carried out to collect information on ingredient type, source, application, and regions for the market. The next step involved validating these findings, assumptions, and sizing with industry experts across the value chain through primary research. The top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, data triangulation was used to estimate the market size of segments and subsegments.

Secondary Research

This research study used extensive secondary sources—directories and databases such as Bloomberg Businessweek and Factiva—to identify and collect information for a technical, market-oriented, and commercial market study. In the secondary research process, sources such as annual reports, press releases, and investor presentations of companies, white papers, nutraceutical ingredients-related journals, certified publications, articles from recognized authors, directories, and databases were referred to identify and collect information. Secondary research was mainly used to obtain key information about the industry’s supply chain, the pool of key players, and market classification and segmentation based on industry trends to the bottom-most level, regional markets, and key developments from market- and technology-oriented perspectives.

Primary Research

Extensive primary research was conducted after obtaining the nutraceutical ingredients market scenario through secondary research. Several primary interviews were conducted with market experts from the demand and supply sides. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as chief experience officers (CXOs); vice presidents (VPs); directors from business development, marketing, research, and development teams; and related key executives from distributors and key opinion leaders.

Primary interviews were conducted to gather insights, including market statistics, revenue data from products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research helped understand various trends related to ingredient type, source, application, and regions.

Stakeholders from the demand side, including dietary supplement manufacturers, functional food and beverage manufacturers, medical and specialized nutrition companies, and infant and early-life nutrition manufacturers, were interviewed to understand buyers’ perspectives on nutraceutical ingredient suppliers, purchasing trends, formulation requirements, and the outlook for the market.

Nutraceutical Ingredients Market Size, and Share

Notes:

  • The three tiers of the companies are defined based on their total revenues in 2025, based on the availability of financial data.
  • Tier 1: Revenue > USD 1 billion; Tier 2: USD 100 million ≤ Revenue ≤ USD 1 billion; Tier 3: Revenue < USD 100 million
  • Others include product managers, R&D managers, technical managers, production managers, procurement managers, sales and marketing managers, business development managers, application specialists, and quality assurance managers.

COMPANY

DESIGNATION

ADM (US)

Senior Scientist, Ingredient Delivery

Roquette Frères (France)

Nutraceutical R&D Manager

Cargill, Incorporated (US)

Protein Business Development

Glanbia PLC (Ireland)

Product Innovation Manager

International Flavors & Fragrances Inc. (US)

Beverage Application Specialist

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The top-down and bottom-up approaches were used to estimate and validate the total size of the nutraceutical ingredients market. These approaches were also used extensively to determine the size of various subsegments in the market.

The research methodology used to estimate the market size includes the following details:

  • The key players in the industry and the overall markets were identified through extensive secondary research.
  • All shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.
  • All possible parameters that affect the market covered in this research study were accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain final quantitative and qualitative data.
  • The research included the study of reports, reviews, and newsletters of top market players, along with extensive interviews for opinions from leaders, such as CEOs, directors, and marketing executives.

Nutraceutical Ingredients Market Top Down and Bottom Up Approach

Data Triangulation

After determining the overall market size from the estimation process explained above, the total market was split into several segments and subsegments. The data triangulation procedure was employed, wherever applicable, to estimate the overall nutraceutical ingredients market and obtain precise statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides. The market size was also validated using the top-down and bottom-up approaches.

Market Definition

There is no standard definition for nutraceutical ingredients globally, and the definition of ‘nutraceuticals’ differs according to region and industrial application. Therefore, for the purpose of this study, nutraceutical ingredients are defined as nutritional, bioactive, or functional ingredients used to provide nutritional value or health-related benefits in human and animal nutrition products. The scope includes ingredients derived from plant, animal, microbial, mineral, and synthetic sources and covers applications such as dietary supplements, functional foods, functional beverages, medical and specialized nutrition, infant and early-life nutrition, companion animal nutrition, livestock nutrition, and aquaculture.

The term “nutraceutical” was coined by Stephen L. DeFelice in 1989 by combining the terms “nutrition” and “pharmaceutical.” DeFelice defined a nutraceutical as a food or part of a food that provides medical or health benefits, including the prevention and treatment of disease.

Key Stakeholders

  • Nutraceutical ingredient manufacturers
  • Vitamin and mineral ingredient manufacturers
  • Amino acid and functional protein manufacturers
  • Omega-3 fatty acid manufacturers
  • Probiotic, prebiotic, and fiber ingredient manufacturers
  • Specialty bioactive ingredient manufacturers
  • Botanical extract and enzyme manufacturers
  • Nucleotide and specialty lipid manufacturers
  • Plant-based, animal-based, microbial-based, and synthetic ingredient suppliers
  • Animal feed ingredient and feed additive manufacturers
  • Dietary supplement manufacturers
  • Functional food manufacturers
  • Functional beverage manufacturers
  • Medical and specialized nutrition manufacturers
  • Infant and early-life nutrition manufacturers
  • Pet food manufacturers
  • Livestock feed manufacturers
  • Aquaculture feed manufacturers
  • Contract manufacturers and formulation service providers
  • Ingredient distributors, importers, and exporters
  • Food, beverage, and dietary supplement brands
  • Animal nutrition and feed brands
  • Research institutes and universities
  • Government and regulatory authorities
    • US Food and Drug Administration (FDA)
    • European Food Safety Authority (EFSA)
    • Food Safety and Standards Authority of India (FSSAI)
    • Health Canada
    • Food Standards Australia New Zealand (FSANZ)
    • Codex Alimentarius Commission (CAC)
  • Industry and trade associations
    • Council for Responsible Nutrition (CRN)
    • International Alliance of Dietary/Food Supplement Associations (IADSA)
    • International Probiotics Association (IPA)
    • International Scientific Association for Probiotics and Prebiotics (ISAPP)
    • International Food Information Council (IFIC)
    • International Feed Industry Federation (IFIF)
    • Animal Nutrition Society of India (ANSI)
  • Certification, testing, and standards organizations
    • NSF
    • USP
    • ISO

Report Objectives

  • To determine and project the size of the nutraceutical ingredients market based on ingredient type, source, application, and region over the forecast period
  • To identify key growth opportunities by analyzing the largest and fastest-growing segments across regions
  • To provide detailed insights on factors influencing market growth, including drivers, restraints, opportunities, and challenges
  • To evaluate market opportunities for stakeholders and present the competitive landscape of leading players
  • To analyze micromarkets with respect to individual growth trends, future potential, and their contribution to the overall market
  • To identify and profile key companies operating in the nutraceutical ingredients market
  • To assess the competitive environment and highlight key strategies adopted by major players across regions.

Available customizations:

With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs. The following customization options are available for the report:

PRODUCT ANALYSIS

  • Product matrix, which gives a detailed comparison of the product portfolio of each company.

GEOGRAPHIC ANALYSIS

With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.

  • Further breakdown of Rest of Europe nutraceutical ingredients by key countries
  • Further breakdown of Rest of Asia Pacific nutraceutical ingredients by key countries
  • Further breakdown of Rest of South America nutraceutical ingredients by key countries

COMPANY INFORMATION

  • Detailed analyses and profiling of additional market players (up to five)

 

Table of Contents

Methodology

 Request Customization Speak to Analyst
Speak to Analyst
Fact checked
Cite this Research

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Nutraceutical Ingredients Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request
Forbes

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

TESTIMONIALS

Growth opportunities and latent adjacency in Nutraceutical Ingredients Market

DMCA.com Protection Status
popup img